To be or not to be (inflamed)—is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?

Inflammatory Blockade Restores Adult Hippocampal Neurogenesis

Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426 · see citing works

Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury

Faulkner, J., Herrmann, J., Woo, M. J., Tansey, K., Doan, N., & Sofroniew, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3547-03.2004 · Cited by 1,600 · see citing works

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies

McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · see citing works

Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · see citing works

Inflammatory mediators in the elderly

Krabbe, K. S., Pedersen, M., & Bruunsgaard, H. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.01.009 · Cited by 928 · see citing works

Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism

Pluchino, S., Zanotti, L., Rossi, B., Brambilla, E., Ottoboni, L., Salani, G., Martinello, M., Cattalini, A., Bergami, A., Furlan, R., et al. (2005) · Nature · doi:10.1038/nature03889 · Cited by 762 · see citing works

Experimental autoimmune encephalomyelitis repressed by microglial paralysis

Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · see citing works

Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease

Chen, H., Zhang, S. M., Hernán, M. Á., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 630 · see citing works

Inflammation and neurodegeneration in Parkinson's disease

McGeer, P. L., & McGeer, E. G. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.01.005 · Cited by 628 · see citing works

The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease

Perry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560 · see citing works

Pro‐regenerative properties of cytokine‐activated astrocytes

Liberto, C. M., Albrecht, P. J., Herx, L. M., Yong, V. W., & Levison, S. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02420.x · Cited by 464 · see citing works

Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases

Mandel, S. A., & Youdim, M. B. H. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.012 · Cited by 443 · see citing works

Visualising microglial activation in vivo

Banati, R. B. (2002) · Glia · doi:10.1002/glia.10144 · Cited by 428 · see citing works

Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies

FRANCHIMONT, D. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.009 · Cited by 408 · see citing works

Genetic and environmental factors in the cause of Parkinson's disease

Warner, T. T., & Schapira, A. H. V. (2003) · Annals of Neurology · doi:10.1002/ana.10487 · Cited by 399 · see citing works

Estrogen receptor-α mediates the brain antiinflammatory activity of estradiol

Vegeto, E., Belcredito, S., Etteri, S., Ghisletti, S., Brusadelli, A., Meda, C., Krust, A., Dupont, S., Ciana, P., Chambon, P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1531957100 · Cited by 384 · see citing works

Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation

Dehmer, T., Heneka, M. T., Sastre, M., DICHGANS, J., & Schulz, J. B. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02210.x · Cited by 382 · see citing works

Environmental Enrichment Rescues Protein Deficits in a Mouse Model of Huntington's Disease, Indicating a Possible Disease Mechanism

Spires‐Jones, T. L., Grote, H., Varshney, N. K., Cordery, P. M., van Dellen, A., Blakemore, C. B., & Hannan, A. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1658-03.2004 · Cited by 367 · see citing works

Cannabinoids and neuroinflammation

Walter, L. M., & Stella, N. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705667 · Cited by 334 · see citing works

Novel anti-inflammatory therapy for Parkinson's disease

Gao, H., Liu, B., Zhang, W., & Hong, J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00176-7 · Cited by 324 · see citing works

Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease

Benner, E. J., Mosley, R. L., Destache, C. J., Lewis, T. B., Jackson-Lewis, V. R., Gorantla, S., Nemachek, C., Green, S. R., Przedborski, S., & Gendelman, H. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400569101 · Cited by 321 · see citing works

Reduced incidence of AD with NSAID but not H2receptor antagonists

Zandi, P. P., Anthony, J. C., Hayden, K. M., Mehta, K. M., Mayer, L. S., & Breitner, J. C. S. (2002) · Neurology · doi:10.1212/wnl.59.6.880 · Cited by 314 · see citing works

Inflammation and Infection in Clinical Stroke

Emsley, H. C. A., & Tyrrell, P. J. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000037880.62590.28 · Cited by 277 · see citing works

Microglia and neuroprotection: implications for Alzheimer's disease

Streit, W. J. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.013 · Cited by 256 · see citing works

Cytokines in Neuroinflammation and Alzheimers Disease

Cacquevel, M., Lebeurrier, N., Chéenne, S., & Vivien, D. (2004) · Current Drug Targets · doi:10.2174/1389450043345308 · Cited by 245 · see citing works

Macrophages and neurodegeneration

Hendriks, J. J. A., Teunissen, C. E., de Vries, H. E., & Dijkstra, C. D. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.008 · Cited by 241 · see citing works

Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones

García‐Ovejero, D., Azcoitia, Í., DonCarlos, L. L., Melcangi, R. C., & García‐Segura, L. M. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.018 · Cited by 220 · see citing works

Peroxisome Proliferator-Activated Receptor α Agonists as Therapy for Autoimmune Disease

Lovett‐Racke, A. E., Hussain, R. Z., Northrop, S. C., Choy, J., Rocchini, A., Matthes, L., Chavis, J. A., Diab, A., Drew, P. D., & Racke, M. K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5790 · Cited by 207 · see citing works

Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: Glia dictates resistance versus vulnerability to neurodegeneration

Morale, M. C., Serra, P. A., L’Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Gennuso, F., Giaquinta, G., Rocchitta, G., Desole, M. S., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.060 · Cited by 207 · see citing works

Neuroinflammatory perspectives on the two faces of Alzheimer?s disease

Eikelenboom, P., & van Gool, W. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0055-1 · Cited by 181 · see citing works

COX‐2 and Neurodegeneration in Parkinson's Disease

Teismann, P., Vila, M., Choi, D., Tieu, K., Wu, D.-C., Jackson-Lewis, V. R., & Przedborski, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07482.x · Cited by 178 · see citing works

Pathogenesis of multiple sclerosis

Prat, A., & Antel, J. P. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169737.99040.31 · Cited by 158 · see citing works

Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives

Mandel, S., Weinreb, O., Amit, T., & Youdim, M. B. H. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.027 · Cited by 157 · see citing works

Interactions between Alzheimer's disease and cerebral ischemia—focus on inflammation

Koistinaho, M., & Koıstınaho, J. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.014 · Cited by 148 · see citing works

Nasal Vaccination with Myelin Oligodendrocyte Glycoprotein Reduces Stroke Size by Inducing IL-10-Producing CD4+ T Cells

Frenkel, D., Huang, Z., Maron, R., Koldzic, D. N., Hancock, W. W., Moskowitz, M. A., & Weiner, H. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6549 · Cited by 147 · see citing works

Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, “protective” glial stem cells and stromal ependymal cells

Hauwel, M., Furon, E., Canova, C., Griffiths, M., Neal, J. W., & Gasque, P. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.012 · Cited by 142 · see citing works

Environmental enrichment reverses learning impairment in the Morris water maze after focal cerebral ischemia in rats

Dahlqvist, P. M., Rönnbäck, A., Bergström, S., Söderström, I., & Olsson, T. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03248.x · Cited by 140 · see citing works

Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review

Willenborg, D. O., Staykova, M. A., & Cowden, W. B. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00212-x · Cited by 136 · see citing works

Cytokine and chemokine inter-regulation in the inflamed or injured CNS

Owens, T., Babcock, A. A., Millward, J. M., & Toft‐Hansen, H. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.007 · Cited by 131 · see citing works

NSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from <i>In Vitro</i> and Animal Models

COLE, G. M., MORIHARA, T., LIM, G. P., YANG, F., BEGUM, A., & FRAUTSCHY, S. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.005 · Cited by 129 · see citing works

New insights into COX-2 biology and inhibition

Patrignani, P., Tacconelli, S., Sciulli, M. G., & Capone, M. L. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.024 · Cited by 128 · see citing works

Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study

Lévecque, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg009 · Cited by 125 · see citing works

Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain

Ling, Z. D., Chang, Q., Lipton, J. W., Tong, C. W., Landers, T. M., & Carvey, P. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.017 · Cited by 114 · see citing works

Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases

Schwartz, M., & Kipnis, J. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.014 · Cited by 110 · see citing works

Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection

Neuhaus, O., Archelos, J. J., & Hartung, H. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00028-2 · Cited by 108 · see citing works

Cholesterol-independent Effects of Statins and New Therapeutic Targets: Ischemic Stroke and Dementia

Miida, T., Hirayama, S., & Nakamura, Y. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.253 · Cited by 97 · see citing works

Cytokine genes and disease susceptibility

Ollier, W. (2004) · Cytokine · doi:10.1016/j.cyto.2004.07.014 · Cited by 96 · see citing works

How the brain repairs itself: new therapeutic strategies in inflammatory and degenerative CNS disorders

Martino, G. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00771-9 · Cited by 86 · see citing works

Interaction of polymorphisms in the genes encoding interleukin‐6 and estrogen receptor beta on the susceptibility to Parkinson's disease

Håkansson, A. S., Westberg, L., Nilsson, S., Buervenich, S., Belin, A. C., Holmberg, B., Sydow, O., Olson, L., Johnels, B., Eriksson, E., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30136 · Cited by 83 · see citing works

Association between the interleukin-1α gene and Alzheimer’s disease: a meta-analysis

Rainero, I., Bo, M., Ferrero, M., Valfrè, W., Vaula, G., & Pinessi, L. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.011 · Cited by 79 · see citing works

Neuroprotection for Parkinson's disease: Prospects and promises

Olanow, C. W., Schapira, A. H. V., & Agid, Y. (2003) · Annals of Neurology · doi:10.1002/ana.10566 · Cited by 75 · see citing works

Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide

Morale, M. C., Serra, P. A., Delogu, M. R., Migheli, R., Rocchitta, G., Tirolo, C., Caniglia, S., Testa, N., L’Episcopo, F., Gennuso, F., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0501fje · Cited by 71 · see citing works

Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter

Hartmann, A., Hunot, S., & Hirsch, É. C. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.004 · Cited by 70 · see citing works

Stress, the immune system and vulnerability to degenerative disorders of the central nervous system in transgenic mice expressing glucocorticoid receptor antisense RNA

Marchetti, B., Morale, M. C., Testa, N., Tirolo, C., Caniglia, S., Amor, S., Dijkstra, C. D., & Barden, N. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00130-8 · Cited by 62 · see citing works

Anti-inflammatory therapy in Alzheimer?s disease: is hope still alive?

van Gool, W. A., Aisen, P. S. S., & Eikelenboom, P. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1146-5 · Cited by 61 · see citing works

Glucocorticoid receptor–nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia–neuron interactions

Marchetti, B., Serra, P. A., Tirolo, C., L’Episcopo, F., Caniglia, S., Gennuso, F., Testa, N., MIELE, E., Desole, S., Barden, N., et al. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.030 · Cited by 58 · see citing works

Enriched environment, nitric oxide production and synaptic plasticity prevent the aging-dependent impairment of spatial cognition

Arnaiz, S. L., D’Amico, G., Paglia, N., Arismendi, M., Basso, N., & Arnaiz, M. D. R. L. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.02.011 · Cited by 53 · see citing works

From proteomics to biomarker discovery in Alzheimer's disease

Ho, L., Sharma, N., Blackman, L., Festa, E. D., Reddy, G., & Pasinetti, G. M. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.025 · Cited by 49 · see citing works

Biomarkers for apoptosis in Alzheimer's disease

Ankarcrona, M., & Winblad, B. G. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1260 · Cited by 46 · see citing works

Modulation of Cyclooxygenase‐2 and Brain Reactive Astrogliosis by Purinergic P2 Receptors

Brambilla, R., & Abbracchio, M. P. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03612.x · Cited by 44 · see citing works

Ligands for peripheral benzodiazepine binding sites in glial cells

Kassiou, M., Meikle, S. R., & Banati, R. B. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.010 · Cited by 40 · see citing works

A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer’s disease

Licastro, F., Veglia, F., Chiappelli, M., Grimaldi, L. M. E., & Masliah, E. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.002 · Cited by 38 · see citing works

Exposure to a Dysfunctional Glucocorticoid Receptor from Early Embryonic Life Programs the Resistance to Experimental Autoimmune Encephalomyelitis Via Nitric Oxide-Induced Immunosuppression

Marchetti, B., Morale, M. C., Brouwer, J. P., Tirolo, C., Testa, N., Caniglia, S., Barden, N., Amor, S., Smith, P. A., & Dijkstra, C. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5848 · Cited by 36 · see citing works

Upregulation of A2A adenosine receptor expression by TNF-α in PBMC of patients with CHF: a regulatory mechanism of inflammation

Capecchi, P. L., Camurri, A., Pompella, G., Mazzola, A., Maccherini, M., Diciolla, F., Lazzerini, P. E., Abbracchio, M. P., & Pasini, F. L. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.04.005 · Cited by 36 · see citing works

Hormone regulation of microglial cell activation: relevance to multiple sclerosis

Drew, P. D., Storer, P. D., Xu, J., & Chavis, J. A. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.020 · Cited by 36 · see citing works

Nonsteroidal Anti-inflammatory Drugs Protect Against Parkinson Neurodegeneration

Schiess, M. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1043 · Cited by 34 · see citing works

High frequency of TNF alleles $minus;238A and $minus;376A in individuals from northern Sardinia

Wirz, S. (2004) · Cytokine · doi:10.1016/j.cyto.2004.02.006 · Cited by 30 · see citing works

A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis

Furlan, R., Kurne, A., Bergami, A., Brambilla, E., Maucci, R., Gasparini, L., Butti, E., Comı, G., Ongini, E., & Martino, G. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.004 · Cited by 26 · see citing works

Introduction.

Marchetti, B., Kettenmann, H., & Streit, W. J. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.002 · Cited by 23 · see citing works

Mecanismos inflamatorios, arteriosclerosis e ictus isquémico: datos de interés clínico y perspectivas

González, L. C. Á., Freijo-Guerrero, M. M., & Sádaba-Garay, F. (2002) · Revista de Neurología · doi:10.33588/rn.3505.2002019 · Cited by 22 · see citing works

Sodium salicylate-induced amelioration of experimental autoimmune encephalomyelitis in Lewis rats is associated with the suppression of inducible nitric oxide synthase and cyclooxygenases

Moon, C., Ahn, M., Jee, Y., Heo, S., Kim, S., Kim, H., Sim, K., Koh, C., Shin, Y., & Shin, T. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.038 · Cited by 20 · see citing works

The fires within.

Weinberg, J. M. (2005) · PubMed · Cited by 14 · see citing works

Cyclo-oxygenase inhibitors and Alzheimer's: are we well ADAPTed?

Pasinetti, G. M., & Pompl, P. N. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00214-4 · Cited by 9 · see citing works

Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial

Aisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5 · see citing works

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention

Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045 · see citing works

Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression

Gao, H., & Hong, J. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 822 · see citing works

Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease

Petzinger, G. M., Fisher, B. E., McEwen, S., Beeler, J. A., Walsh, J. P., & Jakowec, M. W. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70123-6 · Cited by 798 · see citing works

Glial reactions in Parkinson's disease

McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701 · see citing works

Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention

Tansey, M. G., McCoy, M. K., & Frank-Cannon, T. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.004 · Cited by 580 · see citing works

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders

Sas, K., Robotka, H., Toldi, J., & Vécsei, L. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.033 · Cited by 465 · see citing works

Early Release of HMGB-1 from Neurons after the Onset of Brain Ischemia

Qiu, J., Nishimura, M., Wang, Y., Sims, J. R., Qiu, S., Savitz, S. I., Salomone, S., & Moskowitz, M. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600582 · Cited by 405 · see citing works

Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseases

Vegeto, E., Benedusi, V., & Maggi, A. C. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.04.001 · Cited by 356 · see citing works

Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation

Bureau, G., Longpré, F., & Martinoli, M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21503 · Cited by 336 · see citing works

Astrocytes in the damaged brain: Molecular and cellular insights into their reactive response and healing potential

Buffo, A., Rolando, C., & Ceruti, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.014 · Cited by 321 · see citing works

The Concept of Depression as a Dysfunction of the Immune System

Leonard, B. E. (2010) · Current Immunology Reviews · doi:10.2174/157339510791823835 · Cited by 296 · see citing works

Non-steroidal anti-inflammatory drugs in Parkinson's disease

Esposito, E., Matteo, V. D., Benigno, A., Pierucci, M., Crescimanno, G., & Giovanni, G. D. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.02.008 · Cited by 232 · see citing works

microRNAs in Parkinson’s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches

Leggio, L., Vivarelli, S., L’Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Marchetti, B., & Iraci, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122698 · Cited by 216 · see citing works

Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro

Lee, D.-H., Kim, C., & Lee, Y. J. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.10.029 · Cited by 214 · see citing works

Ulcerative colitis exacerbates lipopolysaccharide‐induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease

Villarán, R. F., Espinosa‐Oliva, A. M., Soto, M. S., de Pablos, R. M., Argüelles, S., Delgado‐Cortés, M. J., Sobrino, V., van Rooijen, N., Venero, J. L., Herrera, A. J., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06879.x · Cited by 214 · see citing works

Purinergic signalling in inflammation of the central nervous system

Virgilio, F. D., Ceruti, S., Bramanti, P., & Abbracchio, M. P. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.003 · Cited by 210 · see citing works

Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: Glia dictates resistance versus vulnerability to neurodegeneration

Morale, M. C., Serra, P. A., L’Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Gennuso, F., Giaquinta, G., Rocchitta, G., Desole, M. S., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.060 · Cited by 207 · see citing works

Chronic Stress Enhances Microglia Activation and Exacerbates Death of Nigral Dopaminergic Neurons under Conditions of Inflammation

de Pablos, R. M., Herrera, A. J., Espinosa-Oliva, A. M., Sarmiento, M., Muñoz, M. F., Machado, A., & Venero, J. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-34 · Cited by 201 · see citing works

Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease

Gaki, G. S., & Papavassiliou, A. G. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8294-x · Cited by 200 · see citing works

Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction

Rebola, N., Simões, A. P., Canas, P. M., Tomé, Â. R., de Andrade, G. M., Barry, C. E., Agostinho, P. M., Lynch, M. A., & Cunha, R. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07178.x · Cited by 196 · see citing works

A Wnt1 regulated Frizzled-1/β-Cateninsignaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection

L’Episcopo, F., Serapide, M. F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Pluchino, S., & Marchetti, B. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-49 · Cited by 196 · see citing works

Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease

Armentero, M., Pinna, A., Ferré, S., Lanciego, J. L., Müller, C. E., & Franco, R. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.07.004 · Cited by 193 · see citing works

Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

L’Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Cossetti, C., D’Adamo, P., Zardini, E., Andreoni, L., Ihekwaba, A., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.023 · Cited by 186 · see citing works

Therapeutic approaches to inflammation in neurodegenerative disease

Klegeris, A., McGeer, E. G., & McGeer, P. L. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3280adc943 · Cited by 186 · see citing works

P2 receptors and neuronal injury

Franke, H., Krügel, U., & Illés, P. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0071-8 · Cited by 184 · see citing works

Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury

Sandhir, R., Onyszchuk, G., & Berman, N. E. J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.06.013 · Cited by 184 · see citing works

Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions

Kim, K. H., Lee, D., Lee, H. L., Kim, C.-E., Jung, K., & Kang, K. S. (2017) · Journal of Ginseng Research · doi:10.1016/j.jgr.2017.03.011 · Cited by 184 · see citing works

The endocannabinoid system in targeting inflammatory neurodegenerative diseases

Centonze, D., Finazzi‐Agrò, A., Bernardi, G., & Maccarrone, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.004 · Cited by 180 · see citing works

Parkinson's disease, aging and adult neurogenesis: Wnt/β‐catenin signalling as the key to unlock the mystery of endogenous brain repair

Marchetti, B., Tirolo, C., L’Episcopo, F., Caniglia, S., Testa, N., Smith, J. A., Pluchino, S., & Serapide, M. F. (2020) · Aging Cell · doi:10.1111/acel.13101 · Cited by 185 · see citing works

Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice

Blanchet, J., Longpré, F., Bureau, G., Morissette, M., Paolo, T. D., Bronchti, G., & Martinoli, M. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.03.024 · Cited by 177 · see citing works

Wnt your brain be inflamed? Yes, it Wnt!

Marchetti, B., & Pluchino, S. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.12.001 · Cited by 167 · see citing works

Microglial Involvement in Neuroplastic Changes Following Focal Brain Ischemia in Rats

Madinier, A., Bertrand, N., Mossiat, C. M., Prigent‐Tessier, A., Beley, A., Marie, C., & Garnier, P. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008101 · Cited by 154 · see citing works

Inflammatory processes in the aging mouse brain: Participation of dendritic cells and T-cells

Stichel, C. C., & Luebbert, H. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.07.022 · Cited by 151 · see citing works

Neuroprotection by Spice-Derived Nutraceuticals: You Are What You Eat!

Kannappan, R., Gupta, S. C., Kim, J. H., Reuter, S., & Aggarwal, B. B. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8168-2 · Cited by 150 · see citing works

Interaction of curcumin with Zn(II) and Cu(II) ions based on experiment and theoretical calculation

Zhao, X.-Z., Jiang, T., Wang, L., Yang, H., Zhang, S., & Zhou, P. (2010) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2010.09.049 · Cited by 145 · see citing works

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease

Esposito, E., Impellizzeri, D., Mazzon, E., Paterniti, I., & Cuzzocrea, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041880 · Cited by 144 · see citing works

TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson’s diseases in vivo model

Campolo, M., Paterniti, I., Siracusa, R., Filippone, A., Esposito, E., & Cuzzocrea, S. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.12.003 · Cited by 143 · see citing works

Microglia Isolation from Adult Mouse Brain

Lee, J., & Tansey, M. G. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-520-0_3 · Cited by 141 · see citing works

TNF Production and Release from Microglia via Extracellular Vesicles: Impact on Brain Functions

Raffaele, S., Lombardi, M., Verderio, C., & Fumagalli, M. (2020) · Cells · doi:10.3390/cells9102145 · Cited by 140 · see citing works

Thiamine Deficiency: An Update of Pathophysiologic Mechanisms and Future Therapeutic Considerations

Abdou, E., & Hazell, A. S. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1430-z · Cited by 139 · see citing works

Plasticity of Subventricular Zone Neuroprogenitors in MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine) Mouse Model of Parkinson's Disease Involves Cross Talk between Inflammatory and Wnt/β-Catenin Signaling Pathways: Functional Consequences for Neuroprotection and Repair

L’Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Deleidi, M., Serapide, M. F., Pluchino, S., & Marchetti, B. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5259-11.2012 · Cited by 135 · see citing works

Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson’s Disease

Marchetti, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123743 · Cited by 130 · see citing works

The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis

do Carmo, M. R. S., Menezes, A. P. F., Nunes, A. C. L., Pliássova, A., Rolo, A. P., Palmeira, C. M., Cunha, R. A., Canas, P. M., & de Andrade, G. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.045 · Cited by 129 · see citing works

Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine

Wenk, G. L., Parsons, C. G., & Danysz, W. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00007 · Cited by 128 · see citing works

The Role of Astrocytes in the Neurorepair Process

Chiareli, R. A., Carvalho, G. A., Marques, B. L., Mota, L. S., Oliveira‐Lima, O. C., Gomes, R. M., Birbrair, A., Gomez, R. S., Simão, F., Klempin, F., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.665795 · Cited by 126 · see citing works

Harnessing the anti-inflammatory potential of palmitoylethanolamide

Alhouayek, M., & Muccioli, G. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.007 · Cited by 122 · see citing works

Astrocytes facilitate melanoma brain metastasis via secretion of IL ‐23

Klein, A., Doron, H., Sagi‐Assif, O., Meshel, T., Izraely, S., Ben‐Menachem, S., Bengaiev, R., Ben‐Shmuel, A., Nahmias, C., Couraud, P., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4509 · Cited by 121 · see citing works

Study of Structural stability and formation mechanisms in DSPC and DPSM liposomes: A coarse-grained molecular dynamics simulation

Hashemzadeh, H., Javadi, H., & Darvishi, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-58730-z · Cited by 120 · see citing works

Neuroinflammation in Parkinson's Disease: Is there sufficient evidence for mechanism-based interventional therapy?

Tansey, M. G. (2007) · Frontiers in bioscience · doi:10.2741/2713 · Cited by 120 · see citing works

Roles of P2 receptors in glial cells: focus on astrocytes

Abbracchio, M. P., & Ceruti, S. (2006) · Purinergic Signalling · doi:10.1007/s11302-006-9016-0 · Cited by 116 · see citing works

Incipient Melanoma Brain Metastases Instigate Astrogliosis and Neuroinflammation

Doron, H., Blacher, E., Amer, M., Livneh, N., Abramovitz, L., Klein, A., Ben‐Shushan, D., Soffer, S., Blazquez, R., Barrantes‐Freer, A., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0485 · Cited by 107 · see citing works

Chaperones and proteases

Hinault, M., Ben‐Zvi, A., & Goloubinoff, P. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:3:249 · Cited by 105 · see citing works

The more you have, the less you get: the functional role of inflammation on neuronal differentiation of endogenous and transplanted neural stem cells in the adult brain

Mathieu, P., Battista, D., Depino, A. M., Roca, V., Graciarena, M., & Pitossi, F. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06548.x · Cited by 104 · see citing works

Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs

Tapia‐González, S., Carrero, P., Pernía, O., García‐Segura, L. M., & Diz-Chaves, Y. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0294 · Cited by 101 · see citing works

Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease

Leggio, L., Paternò, G., Vivarelli, S., L’Episcopo, F., Tirolo, C., Raciti, G., Pappalardo, F., Giachino, C., Caniglia, S., Serapide, M. F., et al. (2020) · Biomolecules · doi:10.3390/biom10091327 · Cited by 100 · see citing works

Selective Oestrogen Receptor Modulators Decrease the Inflammatory Response of Glial Cells

Arévalo, M., Diz-Chaves, Y., Santos‐Galindo, M., Bellini, M. J., & García‐Segura, L. M. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02156.x · Cited by 98 · see citing works

Evaluation of the safety and toxicity of the oligomerized polyphenol Oligonol

Fujii, H., Sun, B., Nishioka, H., Aya, H., & Aruoma, O. I. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.08.026 · Cited by 98 · see citing works

Aging-InducedNrf2-AREPathway Disruption in the Subventricular Zone Drives Neurogenic Impairment in Parkinsonian Mice viaPI3K-Wnt/β-CateninDysregulation

L’Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Impagnatiello, F., Pluchino, S., & Marchetti, B. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3206-12.2013 · Cited by 94 · see citing works

Uracil nucleotides: From metabolic intermediates to neuroprotection and neuroinflammation

Lecca, D., & Ceruti, S. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.12.009 · Cited by 92 · see citing works

Increased expression of the γ‐secretase components presenilin‐1 and nicastrin in activated astrocytes and microglia following traumatic brain injury

Nadler, Y., Alexandrovich, A. G., Grigoriadis, N., Hartmann, T., Rao, K. S. J., Shohami, E., & Stein, R. (2008) · Glia · doi:10.1002/glia.20638 · Cited by 93 · see citing works

Uncovering novel actors in astrocyte–neuron crosstalk in P arkinson's disease: the W nt/β‐catenin signaling cascade as the common final pathway for neuroprotection and self‐repair

Marchetti, B., L’Episcopo, F., Morale, M. C., Tirolo, C., Testa, N., Caniglia, S., Serapide, M. F., & Pluchino, S. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12166 · Cited by 91 · see citing works

Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system

Hernández-Romero, M. C., Delgado-Cortés, M. J., Sarmiento, M., de Pablos, R. M., Espinosa-Oliva, A. M., Argüelles, S., Bández, M. J., Villarán, R. F., Mauriño, R., Santiago, M., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.01.018 · Cited by 100 · see citing works

Low molecular proanthocyanidin dietary biofactor Oligonol: Its modulation of oxidative stress, bioefficacy, neuroprotection, food application and chemoprevention potentials

Aruoma, O. I., Sun, B., Fujii, H., Neergheen, V. S., Bahorun, T., Kang, K., & Sung, M. (2006) · BioFactors · doi:10.1002/biof.5520270121 · Cited by 89 · see citing works

Annexin A1 in the brain – undiscovered roles?

Solito, E., McArthur, S., Christian, H., Gavins, F. N. E., Buckingham, J. C., & Gillies, G. E. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.12.003 · Cited by 86 · see citing works

Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain

L’Episcopo, F., Tirolo, C., Serapide, M. F., Caniglia, S., Testa, N., Leggio, L., Vivarelli, S., Iraci, N., Pluchino, S., & Marchetti, B. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00012 · Cited by 84 · see citing works

Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system

Ismaiel, A. A., Espinosa‐Oliva, A. M., Santiago, M., García-Quintanilla, A., Oliva-Martín, M. J., Herrera, A. J., Venero, J. L., & de Pablos, R. M. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.03.004 · Cited by 81 · see citing works

Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease

L’Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Morale, M. C., Serapide, M. F., Pluchino, S., & Marchetti, B. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt053 · Cited by 80 · see citing works

Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges

Serafino, A., Giovannini, D., Rossi, S., & Cozzolino, M. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1746266 · Cited by 78 · see citing works

Potential Role of Natural Polyphenols against Protein Aggregation Toxicity: In Vitro, In Vivo, and Clinical Studies

Henríquez, G., Gomez, A., Guerrero, E., & Narayan, M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00381 · Cited by 83 · see citing works

Nutritional and Phyto-Therapeutic Potential of Papaya (Carica Papaya Linn.): An Overview

Saeed, F., Arshad, M. U., Pasha, I., Naz, R., Batool, R., Khan, A. A., Nasir, M. A., & Shafique, B. (2013) · International Journal of Food Properties · doi:10.1080/10942912.2012.709210 · Cited by 75 · see citing works

Efficacy and mechanism of cGAMP to suppress Alzheimer’s disease by elevating TREM2

Xu, Q., Xu, W., Cheng, H., Yuan, H., & Tan, X. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.07.004 · Cited by 75 · see citing works

The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration

Saravi, S. S. S., Saravi, S. S. S., Arefidoust, A., & Dehpour, A. R. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0021-5 · Cited by 75 · see citing works

Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury

Franke, H., Parravicini, C., Lecca, D., Zanier, E. R., Heine, C., Bremicker, K., Fumagalli, M., Rosa, P., Longhi, L. G., Stocchetti, N., et al. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9366-3 · Cited by 71 · see citing works

Selective estrogen receptor modulators regulate reactive microglia after penetrating brain injury

Barreto, G. E., Santos‐Galindo, M., & García‐Segura, L. M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00132 · Cited by 71 · see citing works

Applications and bioefficacy of the functional food supplement fermented papaya preparation

Aruoma, O. I., Hayashi, Y., Marotta, F., Mantello, P., Rachmilewitz, E. A., & Montagnier, L. (2010) · Toxicology · doi:10.1016/j.tox.2010.09.006 · Cited by 71 · see citing works

Endothelial activation and induction of monocyte adhesion by nontransferrin‐bound iron present in human sera

Kartikasari, A. E. R., Georgiou, N., Visseren, F. L. J., Kats-Renaud, H. J. V., van Asbeck, B. S., & Marx, J. J. M. (2005) · The FASEB Journal · doi:10.1096/fj.05-4700fje · Cited by 69 · see citing works

Abrogated Inflammatory Response Promotes Neurogenesis in a Murine Model of Japanese Encephalitis

Das, S., Dutta, K., Kumawat, K. L., Ghoshal, A., Adhya, D., & Basu, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017225 · Cited by 71 · see citing works

P1 receptors and cytokine secretion

Abbracchio, M. P., & Ceruti, S. (2007) · Purinergic Signalling · doi:10.1007/s11302-006-9033-z · Cited by 70 · see citing works

Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson’s disease

Pattarini, R., Smeyne, R. J., & Morgan, J. I. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.030 · Cited by 70 · see citing works

Molecular effects of fermented papaya preparation on oxidative damage, MAP Kinase activation and modulation of the benzo[a]pyrene mediated genotoxicity

Aruoma, O. I., Colognato, R., Fontana, I., Gartlon, J., Migliore, L., Koike, K., Coecke, S., Lamy, E., Mersch‐Sundermann, V., Laurenza, I., et al. (2006) · BioFactors · doi:10.1002/biof.5520260205 · Cited by 69 · see citing works

Sesamin Modulates Tyrosine Hydroxylase, Superoxide Dismutase, Catalase, Inducible No Synthase and Interleukin‐6 Expression in Dopaminergic Cells Under Mpp+‐Induced Oxidative Stress

Lahaie-Collins, V., Bournival, J., Plouffe, M., Carange, J., & Martinoli, M. (2008) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.1.1.6958 · Cited by 65 · see citing works

S100B secretion is stimulated by IL-1β in glial cultures and hippocampal slices of rats: Likely involvement of MAPK pathway

de Souza, D. F., Leite, M. C., Quincozes‐Santos, A., Nardin, P., Tortorelli, L. S., Rigo, M., Gottfried, C., Leal, R. B., & Gonçalves, C. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.10.012 · Cited by 65 · see citing works

l -DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?

Bel, E. A. D., Bortolanza, M., Pereira, M. D. S., Bariotto‐dos‐Santos, K., & Raisman‐Vozari, R. (2016) · Synapse · doi:10.1002/syn.21941 · Cited by 65 · see citing works

Salvianolic Acid B Attenuates Toxin-Induced Neuronal Damage via Nrf2-Dependent Glial Cells-Mediated Protective Activity in Parkinson’s Disease Models

Zhou, J., Qu, X., Li, Z., Wei-Ji, Liu, Q., Ma, Y., & He, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101668 · Cited by 62 · see citing works

Differential local tissue permissiveness influences the final fate of GPR 17‐expressing oligodendrocyte precursors in two distinct models of demyelination

Coppolino, G., Marangon, D., Negri, C., Menichetti, G., Fumagalli, M., Gelosa, P., Dimou, L., Furlan, R., Lecca, D., & Abbracchio, M. P. (2018) · Glia · doi:10.1002/glia.23305 · Cited by 60 · see citing works

Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling

L’Episcopo, F., Tirolo, C., Peruzzotti‐Jametti, L., Serapide, M. F., Testa, N., Caniglia, S., Balzarotti, B., Pluchino, S., & Marchetti, B. (2018) · Stem Cells · doi:10.1002/stem.2827 · Cited by 59 · see citing works

Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

L’Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Serra, P. A., Impagnatiello, F., Morale, M. C., & Marchetti, B. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-83 · Cited by 59 · see citing works

Death in the substantia nigra: a motor tragedy

Esposito, E., Matteo, V. D., & Giovanni, G. D. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.6.677 · Cited by 59 · see citing works

Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?

Morale, M. C., L’Episcopo, F., Tirolo, C., Giaquinta, G., Caniglia, S., Testa, N., Arcieri, P., Serra, P. A., Lupo, G., Alberghina, M., et al. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.10.011 · Cited by 59 · see citing works

Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson’s model: a promising candidate for the treatment of Parkinson’s disease

Chen, W.-F., Chakraborty, C., Sung, C., Feng, C., Jean, Y., Lin, Y., Hung, H.-C., Huang, T.-Y., Huang, S., Su, T.-M., et al. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0710-2 · Cited by 57 · see citing works

Translocator protein (18 kDa) is involved in the regulation of reactive gliosis

Veiga, S., Carrero, P., Pernia, O., Azcoitia, I., & Garcia‐Segura, L. M. (2007) · Glia · doi:10.1002/glia.20558 · Cited by 62 · see citing works

Conjugated linoleic acid prevents age-dependent neurodegeneration in a mouse model of neuropsychiatric lupus via the activation of an adaptive response

Monaco, A., Ferrandino, I., Boscaino, F., Cocca, E., Cigliano, L., Maurano, F., Luongo, D., Spagnuolo, M. S., Rossi, M., & Bergamo, P. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m079400 · Cited by 56 · see citing works

Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson’s Disease

Leggio, L., Paternò, G., Vivarelli, S., Falzone, G. G., Giachino, C., Marchetti, B., & Iraci, N. (2021) · Aging and disease · doi:10.14336/ad.2021.0527 · Cited by 55 · see citing works

Neurodegeneration and Neuroinflammation in cdk5/p25-Inducible Mice

Muyllaert, D., Terwel, D., Kremer, A., Sennvik, K., Borghgraef, P., Devijver, H., Dewachter, I., & LEUVEN, F. V. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070693 · Cited by 55 · see citing works

Blockade of adenosine A2A receptors prevents interleukin-1β-induced exacerbation of neuronal toxicity through a p38 mitogen-activated protein kinase pathway

Simões, A. P., Duarte, J. A., Agasse, F., Canas, P. M., Tomé, Â. R., Agostinho, P. M., & Cunha, R. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-204 · Cited by 54 · see citing works

Neurodegeneration and cell replacement

Ormerod, B. K., Palmer, T. D., & Caldwell, M. A. (2007) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2006.2018 · Cited by 52 · see citing works

Small Extracellular Vesicles Secreted by Nigrostriatal Astrocytes Rescue Cell Death and Preserve Mitochondrial Function in Parkinson's Disease

Leggio, L., L'Episcopo, F., Magrì, A., Ulloa‐Navas, M. J., Paternò, G., Vivarelli, S., Bastos, C. A. P., Tirolo, C., Testa, N., Caniglia, S., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201203 · Cited by 54 · see citing works

The Neuroprotective Effect of Fisetin in the MPTP Model of Parkinson's Disease

Patel, M. Y., Panchal, H., Ghribi, O., & Benzeroual, K. E. (2012) · Journal of Parkinson s Disease · doi:10.3233/jpd-012110 · Cited by 51 · see citing works

Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor

Iravani, M. M., Sadeghian, M., Leung, C. C. M., Jenner, P. G., & Rose, S. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.01.022 · Cited by 51 · see citing works

Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease

Marchetti, B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101664 · Cited by 49 · see citing works

Anti-Inflammatory Drugs in the Treatment of Neurodegenerative Diseases: Current State

Gilgun‐Sherki, Y., Melamed, E., & Offen, D. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778343091 · Cited by 52 · see citing works

Effects of Anti-inflammatory on Neurodegenerative disorder

Sharma*, N. B. G. (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.22031432

Roles of Inflammation in Neurodegenerative Diseases

Singsai, K., & Sattayasai, J. (2017) · Journal of Basic and Applied Pharmacology · Cited by 1 · see citing works

Inflammation in Neurodegenerative Disease and Injury

Tansey, M. G., & Kernie, S. G. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.00504-0 · Cited by 2 · see citing works

Inflammation in the early stages of neurodegenerative pathology

Khandelwal, P. J., Herman, A. M., & Moussa, C. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.07.002 · Cited by 211 · see citing works